Vergoeding 2019-2023 voor ATC-subgroep J01 : Antibacteriele middelen voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| J01A Tetracyclines | 2.619.200 | 2.484.400 | 3.904.100 | 5.213.400 | 5.423.800 |
| J01B Amfenicolen | 10 | . | . | 11 | . |
| J01C Betalactam-antibiotica penicillines | 10.348.300 | 11.340.000 | 13.651.700 | 16.828.300 | 19.420.800 |
| J01D Overige betalactam-antibiotica | 5.367.300 | 5.537.000 | 6.000.400 | 6.918.400 | 7.965.300 |
| J01E Sulfonamiden en trimethoprim | 1.331.300 | 1.368.300 | 1.410.800 | 1.506.600 | 1.487.700 |
| J01F Macroliden lincosamiden en streptograminen | 4.777.100 | 4.242.700 | 3.167.100 | 3.635.900 | 5.691.300 |
| J01G Aminoglycosiden | 4.384.200 | 4.165.500 | 4.165.800 | 3.872.800 | 3.669.100 |
| J01M Chinolonen | 2.315.300 | 2.415.300 | 2.358.500 | 2.376.200 | 2.634.200 |
| J01X Overige antibacteriele middelen | 10.072.800 | 10.193.400 | 10.836.600 | 10.788.800 | 10.804.100 |
| Totaal | 41.215.510 | 41.746.600 | 45.495.000 | 51.140.411 | 57.096.300 |